Home Winning (and Losing) in Government Tenders Across Southeast Asia

Winning (and Losing) in Government Tenders Across Southeast Asia

30 Oct 2026

For many pharmaceutical companies, winning a government tender is seen as a major commercial milestone.

Large volumes.
National access.
Immediate scale.

But across Southeast Asia, tenders are not just an opportunity.

They are a different game altogether.

And one that many organisations underestimate.

The Assumption: Lowest Price Wins

At a distance, tenders appear straightforward.

Submit the lowest competitive price.
Meet the technical requirements.
Secure the contract.

But in reality, across Southeast Asia:

Tenders are not purely price-driven.

Price matters — often significantly.

But it is only one part of a much more complex equation.

The Reality: Tenders Are System-Driven

Government tenders are shaped by:

This means that success is not just about pricing.

It is about understanding how the system works in each market.

Country Comparison: Indonesia vs Thailand vs Philippines vs Vietnam

To illustrate how different tender dynamics can be, consider four key markets.

Indonesia: Volume, Price, and Local Execution

What drives success:

Common pitfall:

Underestimating the importance of local presence and operational capability.

Thailand: Structured, But Scheme-Dependent

What drives success:

Common pitfall:

Treating Thailand as a purely centralised tender system.

Philippines: Decentralised and Relationship-Driven

What drives success:

Common pitfall:

Assuming a uniform national procurement approach.

Vietnam: Evolving but Highly Structured

What drives success:

Common pitfall:

Underestimating administrative and regulatory complexity.

The Real Insight

The difference is not just in tender rules.

It is in:

Indonesia is scale- and price-driven.
Thailand is scheme- and value-influenced.
Philippines is network- and execution-driven.
Vietnam is process- and compliance-driven.

And that fundamentally changes how tender strategies must be designed.

The Hidden Risk: Winning the Tender, Losing the Market

One of the biggest misconceptions is equating tender success with commercial success.

In reality:

Winning at the wrong price can lead to:

In some cases, companies win tenders…

But lose profitability — or even strategic flexibility.

The Importance of Execution

Another critical factor often overlooked:

Winning the tender is only the beginning.

Execution determines whether the opportunity is realised.

This includes:

In many Southeast Asian markets, execution gaps — not strategy — determine outcomes.

What Successful Organisations Do Differently

The organisations that consistently succeed in tenders:

They do not chase every tender.

They choose the right ones to win.

My Reflection

Across Southeast Asia, tenders are often viewed through a global lens.

But they do not operate on global logic.

They operate on local realities.

Because in this region:

Winning the tender is not about being the cheapest.
It is about being the most prepared for how the system actually works.

How Lumeos Can Help

Success in government pharmaceutical tenders requires more than competitive pricing. It calls for an understanding of local procurement systems, market conditions and commercial execution. Lumeos Launch™ helps life sciences companies assess market-specific commercialization challenges and strengthen their launch strategies.